Knoll says it plans to do a two-year large study comparing the two drugs after Meridia is approved.
32.
Redux and Meridia work by altering levels of chemicals in the brain, thereby tricking a person into feeling full.
33.
In the two weeks she's been taking Meridia, she's cut her food intake by half.
34.
Knoll's strategy is to position Meridia as a health improvement product, not just a weight loss tool.
35.
Meridia's expected approval isn't all bad news for Lexington, Massachusetts-based Interneuron, analysts said.
36.
And the same FDA panel last year expressed concerns about the potential of Knoll's Meridia to raise blood pressure.
37.
Sepracor has new versions of Meridia under development for depression, attention deficit disorder, erectile dysfunction and urinary stress incontinence.
38.
In 2006 he founded Meridia Capital Partners, a private equity fund management firm specialized in private equity and real estate.
39.
If approved, Meridia would have competed with Interneuron Pharmaceutical Inc .'s Redux, approved by the FDA in April.
40.
Both Redux and Meridia affect a naturally occurring chemical in the brain called serotonin, though they do it in different ways.
